Status:

TERMINATED

Transcutaneous Auricular Vagus Nerve Stimulation to Enhance Motor Learning

Lead Sponsor:

VA Pittsburgh Healthcare System

Conditions:

Neurological Injury

Motor Disorders

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Vagus nerve stimulation (VNS) activates neural pathways leading to the release of chemicals that promote plasticity and learning. Previous work has shown that the auricular branch of the vagus nerve i...

Eligibility Criteria

Inclusion

  • (For prospective subjects diagnosed with stroke)
  • Confirmed diagnosis of a single stroke at least six months prior to participation

Exclusion

  • History of vestibular disorders or dizziness
  • Diagnosis of neurological disorders affecting movement
  • Ocular disease and/or impairment in more than one eye
  • Pregnant or expecting to become pregnant
  • Difficulty maintaining alertness and/or remaining still

Key Trial Info

Start Date :

June 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2023

Estimated Enrollment :

4 Patients enrolled

Trial Details

Trial ID

NCT05316519

Start Date

June 1 2022

End Date

December 31 2023

Last Update

May 9 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Human Engineering Research Laboratories

Pittsburgh, Pennsylvania, United States, 15206

Transcutaneous Auricular Vagus Nerve Stimulation to Enhance Motor Learning | DecenTrialz